These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26458633)

  • 1. The effect of bevacizumab for bone scintigraphy imaging: A case report.
    Asano T; Takakuwa O; Maeno K; Oguri T; Niimi A
    J Cancer Res Ther; 2015; 11(3):652. PubMed ID: 26458633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
    Moragas M; Soler M; Riera E; García JR
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flare phenomenon following gefitinib treatment of lung adenocarcinoma with bone metastasis.
    Hashisako M; Wakamatsu K; Ikegame S; Kumazoe H; Nagata N; Kajiki A
    Tohoku J Exp Med; 2012 Oct; 228(2):163-8. PubMed ID: 23036980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
    Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
    Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold metastases detected by bone scintigraphy in aggressive lung cancer.
    Martínez Carsí C; Ruíz Hernández G; Sánchez Marchori C; Oro Camps J; Perales Vila A
    Nuklearmedizin; 1998; 37(8):292-6. PubMed ID: 9868712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung.
    de Lima Lopes G; Segel JE; Tan DS; Do YK; Mok T; Finkelstein EA
    Cancer; 2012 Feb; 118(4):1032-9. PubMed ID: 21792863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations.
    Shen YC; Tseng GC; Tu CY; Chen WC; Liao WC; Chen WC; Li CH; Chen HJ; Hsia TC
    Lung Cancer; 2017 Aug; 110():56-62. PubMed ID: 28676220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma of the lung with rare insertion mutation in EGFR exon 19 that had partial response to gefitinib: a case report.
    Kozlov V; Karpov I; Kovalenko S; Shamanin V
    Exp Oncol; 2017 Jul; 39(2):155-156. PubMed ID: 29483495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral pulmonary metastases from Ewing's sarcoma shown in a technetium-99m-methylene-diphosphonate bone scan.
    Gholamrezanezhad A; Moinian D; Mirpour S; Hajimohammadi H
    Hell J Nucl Med; 2006; 9(3):181-3. PubMed ID: 17160160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy.
    Yang CJ; Hung JY; Tsai MJ; Wu KL; Liu TC; Chou SH; Lee JY; Hsu JS; Huang MS; Chong IW
    BMC Pharmacol Toxicol; 2017 May; 18(1):21. PubMed ID: 28486985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term response to gefitinib and crizotinib in lung adenocarcinoma harboring both epidermal growth factor receptor mutation and EML4-ALK fusion gene.
    Chiari R; Duranti S; Ludovini V; Bellezza G; Pireddu A; Minotti V; Bennati C; Crinò L
    J Clin Oncol; 2014 Mar; 32(9):e30-2. PubMed ID: 24419120
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients.
    Tseng YH; Tseng YC; Lin YH; Lee YC; Perng RP; Whang-Peng J; Chen YM
    Oncologist; 2015 Jul; 20(7):758-66. PubMed ID: 26054633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.
    Ichihara E; Hotta K; Nogami N; Kuyama S; Kishino D; Fujii M; Kozuki T; Tabata M; Harada D; Chikamori K; Aoe K; Ueoka H; Hosokawa S; Bessho A; Hisamoto-Sato A; Kubo T; Oze I; Takigawa N; Tanimoto M; Kiura K
    J Thorac Oncol; 2015 Mar; 10(3):486-91. PubMed ID: 25695221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current two EGFR mutations in lung adenocarcinoma -  case report.
    Svaton M; Pesek M; Chudacek Z; Vosmiková H
    Klin Onkol; 2015; 28(2):134-7. PubMed ID: 25882025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of gefitinib maintenance in unselected patients with metastatic primary lung adenocarcinoma: A descriptive study.
    Kumar R; Dubashi B; Kayal S; Lazzar SC; Barathi D; Kumar V
    Indian J Cancer; 2017; 54(1):188-192. PubMed ID: 29199688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by (99m)Tc-MDP bone scintigraphy.
    Yang S; Dong Q; Yao M; Shi M; Ye J; Zhao L; Su J; Gu W; Xie W; Wang K; Du Y; Li Y; Huang Y
    Nucl Med Biol; 2009 Apr; 36(3):313-21. PubMed ID: 19324277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluating the short-term effect of gefitinib in advanced lung adenocarcinoma with positive EGFR-mutant by dual source volume perfusion CT].
    Xiong Z; Hu CP; Liu JK; Lu RL; Zhou H; Zhou ML; Chen W
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2824-7. PubMed ID: 22333542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft tissue metastases and lung cancer recurrence detected by Tc-99m depreotide scintigraphy.
    Miliziano JS; Bradley YC
    Clin Nucl Med; 2002 Jun; 27(6):410-2. PubMed ID: 12045431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of lung adenocarcinoma wtih exon19 and T790M mutations in EGFR having good response to erlotinib after gefitinib treatment failure].
    Tanaka H; Okamoto T; Shinyama M; Matsumura S; Fujii T
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1067-9. PubMed ID: 23986053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.